Designing Treatment with the

Three Pillars
IAH AC Designing Treatment with the
Three Pillars

© IAH 2007

1
 Development of Disease

© IAH 2007 2

When therapeutically approaching a pathology, it is important to remember that a

disease has a distinct progression in the body.
First the body will deal with any disturbance at the level of the autoregulatory
system, but if this system is not working properly, or if is overloaded, the disease
process will be shifted to the matrix, and lastly to the cell.
Depending on the stage of the disease, we will apply the so-called three pillars of
treatment differently.
This will be the purpose of the present lecture.

2
 Every disease process of a patient is a journey for
the practitioner…

• For a journey one needs

• A Map
• To know the terrain you are going to cross
• Select the appropriate vehicle
• Select the appropriate fuel

© IAH 2007 3

To get to a structured treatment plan, we need to go through the conventional

steps to arrive at a diagnosis. However, in Homotoxicology other factors are
taken into account, such as the toxic history, as well as the various other factors
which may have impacted on this particular patient..
To get to any comprehensive treatment plan, we have to know where to start,
and also have a way to monitor the progress or evolution of the patients.
With conventional blood work, this is often not possible, to monitor all diseases
with serum markers, or they do not correlate with the state of illness (e.g.
Rheumatoid factor in RA or viral count in Hepatitis C).
It is thus useful to have a different way to measure the progress of a patient and
to know when to adjust treatment.
In homotoxicology this is done according to the Disease Evolution Table (DET).
This is explained in other lectures.

3
 Planning treatment with antihomotoxic medicine

• The Map − The Disease Evolution Table

• The Territory − The Greater Defense System
• The Vehicle − The three pillars
• The Fuel − The medications with different combinations
• According to the pharmacological groups (Plants, minerals,
catalysts etc.)
• According to the composition (basic, compositum, homaccord
etc.)

© IAH 2007 4

In homotoxicology, the map is the DET. This is useful for a couple of reasons
which will be explained subsequently.
The terrain we are working on is the so-called Greater Defense System, which
include all the organs that have to do with auto regulation,
thus, the actual system where defense takes place. We apply the three pillars in
order to manipulate the greater defense system
The three pillars are the bread and butter treatment for regulation on the DET.
Lastly, medications can be applied more specifically to achieve different goals in
the different pillars, and the correct decision needs to be taken on this.

4
 Why is the DET such a good tool?

• Can establish the prognosis of the

patient
• Planning and adjusting the
therapy
• Following the health progression
during treatment

© IAH 2007 5

The DET is a practical tool:

Firstly, it can give us an idea of the regulatory reserve capacity of a patient. If the
patient is on the left side of the regulatory division, it means that the he/she is still
able to regulate. If the patient is on the right side of the regulation/compensation
division, we know that there may be only compensatory mechanisms and we
need to stimulate the regulation in these patients. The tools on the different sides
of the division are different.
The DET is thus assisting in planning a treatment, and furthermore also give us
an indication of prognosis and an indication of the need to use concomitant
therapies, but also whether a patient needs to still take adjuvant allopathic
therapy at the same time. The better a patient can regulate, the less the patient
will need additional support from allopathic drugs.
Once the therapy is selected, the DET can also be used to in fact follow
treatment.
The intervals where patients are reassessed should become longer if the patient
is classified initially on the left of the regulation/compensation division.
A good interval is 6 weeks at a time, to see whether the patient has made any
shifts towards health progression or recovery.

5
 Di
se
as
e ev
ol
ut
io
n

© IAH 2007 6

Disease evolution is a worsening movement towards the right side of the DET.
The disease progression can be followed in many modern diseases, such as for
e.g. hepatitis C, progressing to fatty liver, fibrosis and possibly even cancer.
Also in diseases such as the metabolic syndrome as well as in diabetes, a similar
progression is observed (from inflammation to chronic inflammation in diabetes,
as well as a higher incidence of cancer).

6
 He
alt
h
ev
ol
ut
io
n

© IAH 2007 7

Health evolution implies the opposite movement (or improvement).

This is of major interest in the treatment of patients with homotoxicology.
In the treatment thus, the aim is to see the patient moving from the right to the left
of the chart.
Patients on the right of the chart are often in a “rigidity pattern”, which means that
they do not get acute banal disease during a chronic disease stage, such as RA
and cancer.
Acute inflammation without fibrosis is a good phenomenon, which is purposeful. It
is thus something we would like to see when treating patients with a biological
therapy.
Not all patients will move towards health progression in this way, as many
patients will just present with phenomena which fall in the deposition phase, an
increase in skin tags for instance, but acute inflammation is a very powerful
manifestation with which we can see that a patient is getting better.
The challenge in this is often to induce acute reactions which will resolve without
becoming chronic and at the same time resolve the chronic inflammation without
fibrosis.

7
 Classification of the patient on the DET

• See flow chart in DET − Practical Exercises, e.g. Lymphoma

Dedifferentiation

Lymphodermal

© IAH 2007 8

The first step is thus to classify the patient on the six phase table (DET), which is
done according to the following flow chart. (The next slide).

8
 The importance of the horizontal axis

• Gives an idea how well the patient

regulates in face of the toxin, and
reflects the most up to date status
of the patient
• In the history though one can
follow the stages which the
patient has gone through
• Treatment is always planned
according to the phase which is
the furthest on the right

© IAH 2007 9

The horizontal axis will give an idea of the ability of the patient to regulate, in the
presents of the toxic load. The disease as it is presented is a sign of a purposeful
defense of the body.
The progression of the disease is thus also a sign of success or failure of the
defense system to regulate.
By taking the classification to the extreme right on the table, we will have a status
of this in real time.
We thus also start our treatment in this phase.
Please refer to the lecture on the DET for details on how to use the table.

9
 The importance of the vertical axis

• Gives an indication of the tissue

most affected in the patient
• This may be genetically pre-
disposed
• The locus minoris resistentae
• The embryological layers make it
possible to treat different layers in
the same organ and also follow
disease in the same organ

© IAH 2007 10

The vertical axis gives information on the tissue the patient has been vulnerable
to develop the disease.
Thus, it may be genetically determined.
The emergence of the knowledge on the genomic so-called SNP’s or single
nuclear polymorphisms, explains many of these effects.
As a human race we have basically all of our genes (99.99 %) identical, except
the 0,01 % which is variable and will account for the different responses of
individuals in the same environment.
These SNP’s are emerging as possible predictors of susceptibility of patients to
diseases.
For instance, if a number of patients are exposed to external cortisone over time,
not all patients will develop all the side effects and to the same degree in all
systems.
We will see, for instance, that in some patients this will present as a gastric ulcer,
in others as osteoporosis, still in others as metabolic syndrome and diabetes, and
again in others with Cushing’s disease.
By breaking up the tissues in their embryological origin, we can also follow up the
shift of disease in the same organs. For example, asthma may move towards
health progression from the endodermal organodermal respiratory phase over the
endodermal mucodermal phase as in acute bronchitis.
This is a positive shift in disease evolution.

10
The territory

The autoregulatory system

© IAH 2007

11
 The Autoregulatory System

The Immune
The System
Hypothalamic
pituitary The Nervous
hormonal axis System

Cellular
Respiration
The Neural
Reflexes
The
Mucosal
The Liver Surfaces

© IAH 2007 12

The autoregulatory system ensures homeostasis in an open system, such as is

the human body. It means that when a disturbance enters the system, or there is
an internal disturbance in homeostasis, such as an overproduction of hormones
and neurotransmitters, the whole system which is inter-connected reacts
simultaneously.
However, due to the individual differences mentioned before, some patients will
have a weak spot in one or the other system.
We see for instance those patients who had a lot of stress as children are less
able to regulate over the hypothalamic-pituitary-adrenal axis when they are older.
This means that they may be more prone to develop adrenal burnout, or even
immune syndromes.
In cases like these it is often better to choose the products in the immune
regulation or organs regulating pillar to encompass an extract of hypothalamus
and also glandula suprarenalis as we see for instance in Tonsilla compositum, or
we would use Berberis-Homaccord for a longer period, as it has functiotropic
properties for the adrenal gland.

12
 Regulatory Systems

• Three characteristics:
• Interaction
• Feedback
• Oscillation and Rhythm

• Want to restore all three and observe all three

© IAH 2007 13

In restoring the function of the autoregulatory system, the antihomotoxic

medicines are well suited; as it does not interfere with normal negative feedback
mechanisms of the autoregulatory system (it merely supports the organs of the
autoregulatory system).
Whenever we treat the organs of the autoregulatory system we need to observe
and restore the following: The interaction between the various organ
systems.
One can actually enter the system from any point, be it through the immune
system, the endocrine system, the matrix or the liver via detoxification.
In most cases we enter over the liver and matrix, as this is the system which
ensures proper communication between different regulatory systems. In some
cases though, we would enter the system through the immune system first, for
instance when we have a disease in the organs of detoxification, such as in
hepatitis C.
In other cases we would like to support the whole system first, as it may be the
case in many frail cancer patients, where we would not like to induce health
progression to aggressively. In these cases we would then first support the
organs.

13
 Regulatory Systems

• Three characteristics:
• Interaction
• Feedback
• Oscillation and Rhythm

• Want to restore all three and observe all three

© IAH 2007 14

It is important to observe the negative feedback. In the normal physiological

state, there is always a counter-measure immediately activated with every active
process in the body. Thus with inflammation will activate both pro-inflammatory
cytokines, but at the same time repair mechanisms such as the activation of the
TGF-beta.
A very important feature of open biological systems is oscillation. We see for
instance a biorhythm in most of the processes in the body.
For example, cortisol has a peak at 08:00 and low ebb at 00:00.
This is also important for the matrix, which then becomes slightly inflammatory
when cortisol is at the ebb. This is also balanced with an acid phase in the matrix.
These three events will then allow detoxification in the matrix.
When we treat any condition we would like to restore the normal interaction,
feedback and also restore the biorhythm.
This is extremely difficult to achieve with anything that has a suppressive action.

14
 Regulatory Systems

• Three characteristics:
• Interaction
• Feedback
• Oscillation and Rhythm

• Want to restore all three and observe all three

© IAH 2007 15

As already stated, a very important feature of open biological systems is

oscillation.
This is also reflected in the immune system, where TH1 is slightly dominant in the
early hours of the morning, followed by TH2 later in the day.
This small oscillation around the baseline is seen in most physiological systems
When we treat any condition we would like to restore the normal interaction,
feedback, and also restore the biorhythm. .
This is extremely difficult to achieve with any drug which has a suppressive
action.
Antihomotoxic medicine, acting on the greater defense system, using the body’s
own systems, is ideal for this purpose.

15
The vehicle

The three pillars of homotoxicology

© IAH 2007

16
 Three Pillars of Homotoxicology

DETOXIFICATION IMMUNOMODULATION ORGAN REGULATION

AND DRAINAGE AND
CELLULAR ACTIVATION

© IAH 2007 17

The three pillars of homotoxicology is the vehicle we use to influence the

greater defense system, and to navigate the patient over the six phase table.
The three pillars are used individually, and especially on the left side of the
regulation/compensation division, it is often enough to use only a basic
detoxification and drainage, a simple immune modulation, as well as functiotropic
organ support.
For this we mainly use basic preparations and homaccords.
When we are dealing with more serious illness, as is seen on the right of the
regulation/compensation division, we use organ support with tissue extracts as
well as cellular activation, and a deeper support of the detoxification and
drainage. The immune-modulation often has a component of tissue support as
well.
We do not necessarily use the three pillars in a specific order, but usually
detoxification and drainage will be the first intervention, as toxicity plays such a
major role in many disease processes. Sometimes, however, as mentioned
earlier, detoxification and drainage will be a later event, such as in cancer
patients on active chemo, and patients with disease processes of the detox and
drainage tissues, such as Chronic Active Hepatitis.

17
Three Pillars of Homotoxicology

DETOXIFICATION
AND DRAINAGE

© IAH 2007 18

18
 Detoxification and Drainage

Functional support Organ support of the detoxification

and drainage and elimination organs

© IAH 2007 19

In all three pillars we see a basic approach and an advanced approach.

In general, the basic approach is mostly used for patients on the left of the
regulatory division, and the advanced on the right.
Sometimes tools like questionnaires are used, together with a flow chart to select
therapy. This will be discussed in more advanced seminars.
In patients who have a high toxic burden, it is wise to first support and strengthen
the organs of detoxification and drainage with organ preparations, before the
toxins are drained out of the tissues with a product like Lymphomyosot.
The homaccords contained in the detox kit will have a functiotropic effect; in other
words support the function of the organ, rather than the structure and cells. It is
thus organ regulating on a more functional level.
The next slide gives a synopsis of the various products used for advanced
support and the basic support and drainage.

19
 Detoxification and Drainage
Basic Advanced

Liver Urinary tract/ Lymph Skin Gut Gallbladder Connective Respiratory

Kidney tissue tract

Detox-Kit Detox-Kit Detox-Kit Detox-Kit Chelidonium- Detox-Kit Bronchalis-

- Homaccord Heel
Solidago Hepar comp. Thyreoidea
Hepar comp. comp. Tonsilla comp. Cutis comp. Mucosa comp. comp. Mucosa comp.
Coenzyme Coenzyme Coenzyme Coenzyme Coenzyme Coenzyme Coenzyme Coenzyme
comp./ comp./ comp./ comp./ comp./ comp./ comp./ comp./
Ubichinon Ubichinon Ubichinon Ubichinon Ubichinon Ubichinon Ubichinon Ubichinon
comp. comp. comp. comp. comp. comp. comp. comp.

Glyoxal compositum

© IAH 2007 20

For each organ there is a product which will support the tissues. These are
mostly the so called compositum preparations which also contain tissue extracts,
and often catalysts. And there are basic preparations which are combinations of
plant materials, and also minerals on the other hand are mostly (but not only)
used to stimulate elimination.
The general basic detoxification:
This regime is often used initially in patients with mild to moderate toxicity. With
this basic regime, we want to support the liver, gut and kidney and drain the
matrix of toxins as well as help the excretion.
These preparations come in drop-form, and 30 drops of each can be added to a
1, 5 litre bottle of water to be taken over the day. This is thus a convenient
method to deliver the medications.

20
 Detoxification and Drainage
Basic Advanced

Liver Urinary tract/ Lymph Skin Gut Gallbladder Connective Respiratory

Kidney tissue tract

Detox-Kit Detox-Kit Detox-Kit Detox-Kit Chelidonium- Detox-Kit Bronchalis-

- Homaccord Heel
Solidago Hepar comp. Thyreoidea
Hepar comp. comp. Tonsilla comp. Cutis comp. Mucosa comp. comp. Mucosa comp.
Coenzyme Coenzyme Coenzyme Coenzyme Coenzyme Coenzyme Coenzyme Coenzyme
comp./ comp./ comp./ comp./ comp./ comp./ comp./ comp./
Ubichinon Ubichinon Ubichinon Ubichinon Ubichinon Ubichinon Ubichinon Ubichinon
comp. comp. comp. comp. comp. comp. comp. comp.

Glyoxal compositum

© IAH 2007 21

The general advanced detoxification:

The purpose of this advanced detoxification is to support the organs of detoxification, especially in
patients with a high toxic burden, or in patients where the organs of detoxification and drainage
are not functioning optimally. This is also true for patients who are debilitated.
In these patients it is very important not to increase the load of toxins too early, as these patients
often already have genotoxic effects of toxins or active cancer. For instance, if a patient with
breast cancer is highly contaminated with DDT, which is an estrogenic like substance, it can act
as a promoter for the cancer. Experiments with ovarectomized mice have shown that the mice can
develop breast cancer if they are intoxicated with DDT, then ovarectomized so that there is no
internal source of estrogens. The mice then developed breast cancer from the release of DDT
from the tissues. (Bigsby et al., 1997)
It is thus wise to go slowly in patients with decreased detox ability, or high loads of toxins as well
as in obese patients which could store a number of lipophilic toxins. Fasting should be avoided in
most patients for this reason, as fasting causes a very quick release of toxins from the storage
compartments into the blood stream due to the fact that there are no immediate toxins coming in
from the food, and the elimination and detox organs will then turn their attention to older stored
toxins and these may then be released in large amounts and at once.
The advanced detoxification products aim to support the major organs of detoxification and
drainage. These products are mostly composita preparations, which implies that they have a
special formulation with plant and mineral material, but then also contain organ extracts of the
specific target organs, or tissue which will support the target organs, as well as catalysts and
sometimes vitamins in dilution.

21
 Clinical Immunomodulation

Possible with amino acids: plants,

suis organs, venoms, nosodes

© IAH 2007

The next pillar is immunomodulation. Mostly we want to manipulate the

cellular immunity, thus the T cells, which also have the memory function in higher
animals.
This can be achieved usually only with amino acids, but also with for instance
lipopolysaccarides from bacterial cell walls.
Amino acids in antihomotoxic preparations are found in plants, animal material
such as Suis organs, nosodes, as well as venoms. In this case, the dilution is
also of importance, as we only achieve induction of T reg cells in a dilution of D1
–D14. (see lecture on immunomodulation).

22
 Immunomodulation

Basic functional With organ support

© IAH 2007 23

Again we have a basic and an advanced immunomodulation.

The basic immunomodulation is often achieved with plants and/or venoms alone,
like in Gripp Heel, or Traumeel, whereas in more severe conditions, like
autoimmunity, will need deeper support in the form of organ tissues in order to
achieve oral tolerance to the affected organ.
Basic immunomodulation is often combined with the organ extracts, as these are
also tissue supporters and will be used in the regime for organ support.
Examples of basic support is Traumeel and Lymphomyosot, which will reduce
inflammation (down-regulate TH1), and Engystol, which will up-regulate TH1 (see
next slide).
Examples of advanced support will be Tonsilla comp which contains tissue
extract of all the major organs and will up-regulate TH1, and Echinacea comp,
which again will down-regulate TH1.

23
 TH0 Co
EA rti
s
DH ol
TH3

TH1 TH2

IL-2 IL-4, 13
IFN gamma TGF-beta IL-5
TNF IL-10

To down regulate use Traumeel, To down regulate use

Echinacea compositum Engystol, Tonsilla compositum

© IAH 2007 24

There is of course another aspect to immune regulation, which was discussed in

the lecture on immune-modulation.
This is the aspect of immune rigidity, where a patient favours a specific
subclass of CD4 cells.
Allergic patients will have TH2 predominance, whereas patients with inflammatory
conditions will have TH1 predominance.
To down-regulate the different subclasses and up-regulate the others, we use
regulatory drugs, and therefore will induce TH3 (T-reg) cells in order to balance
the TH1 TH2 equation.
Traumeel is thus such an inflammation regulating drug.

24
 Three Pillars of Homotoxicology:

ORGAN REGULATION

© IAH 2007 25

Organ regulation has two aspects, namely the support of the organ tissue and
function, and very importantly the activation of cellular energy.
From the lecture on organ regulation, it should be clear how important this aspect

25
 Organ regulation and cellular activation

Functiotropic Organotropic

© IAH 2007 26

Functiotropic support is done by mainly basic combinations and homaccords,

thus with plants and minerals, whereas the organotropic support is done with
tissue extracts. These are to be found in the composita.
Certain basic homaccords, such as Hepeel, has been shown to have anti-oxidant
and an anti-proliferative effect in vitro, and as such is then organ protective in
many instances, such as in detoxification and in viral disease. (Gebhardt 2004)

26
 Organ regulation and cellular activation

Cellular energy activation

Basic Advanced

© IAH 2007 27

Also in cellular activation we have the basic catalysts, which will support the
Krebs’s cycle and more advanced catalysts, which will support the respiratory
chain, and even hypothetically protect against glycolic respiration as is seen in
cancer cells (Glyoxal comp).
The latter two are thus of real use in Cancer Therapies and degenerative
diseases, whereas Coenzyme comp, is a good basic support of cellular energy.

27
The Fuel

The antihomotoxic medication

© IAH 2007

28
 Classification of medications by way
of ingredients

• By Pharmacological groups (PG’s):

• Plants, PPG
• Minerals, MPG
• Catalysts, CPG
• Organ regulator pharmacological group ORPG
• This includes organ preparations (organ regulator and
immunomodulator)
• Venoms (Immunomodulator)
• Nosodes (Deep Immunomodulator)

© IAH 2007 29

In order to see whether we have enough ‘fire power’ to treat the disease
according to severity (always refer to DET), we can double check our prescription
once we have made the choice.
In general, we use plants and minerals (so-called PPG’s and MPG’s) on the left
of the regulation/compensation division, but as soon as we move to the right of
the division, we need to add catalysts (CPG’s) and organ regulators (ORPG).
As the disease is classified more to the right of the table, the more we need to
add all the pharmacological groups.
If we choose the basic or advanced treatment in each pillar, this is almost always
automatically correct, but it is good to “check” the prescription.

29
 Classification of medication by way
of composition

• By type:
• Special Heel preparations
• Homaccords
• Compositums
• Catalysts
• Mixed Injeels
• Injeels

© IAH 2007 30

Another check of the prescription is made over the preparation groups, as we use
basic preparations and homaccords on the left side of the DET, and add catalysts
and composita on the right.

30
 Treatment plan on disease evolution table

Detoxification Cellular activation Organ regulation and

and drainage advanced immuno-
Basic immunomodulation modulation

PLANTS MINERALS CATALYSTS NOSODES

VENOMS
SARCODES
Basic combinations
Homaccords
Catalysts
Composita

© IAH 2007 31

This is a summary of what we have already said in the above.

31
 Steps in planning treatment

1. Classify the patient on the DET

2. Choose the pillar appropriate for the disease
3. Choose the appropriate medication
4. Check the appropriateness of the prescription

© IAH 2007 32

Thus, when we have taken a full history, we go through the following steps:
We classify the patient on the DET, and we use the most right sided classification
to plan treatment.
This means, if a patient with liver cirrhosis went trough the stages of fatty
infiltration (deposition) and chronic active inflammation (impregnation), but now
presents in the degenerative phase with cirrhosis, we start from this point,
although there may still be signs of the other precursor stages.
After that, we need to see if we require one, two or all three pillars. Generally, the
more to the left the patient’s disease is classified, the less pillars we need, and
more basic the treatment needed.
If we have now chosen the pillar(s), we need to choose the appropriate treatment
within the pillar(s).
This is the basic and advanced approach.
Lastly, we can double check our prescription:
E.g. do we have composita and catalysts if the patient is on the right side of the
division, and do we have all the pharmacological groups, thus PPG’s, MPG’s,
CPG’s and ORPG’s?

32
Flow chart
Classify on DET

Choose pillar

Choose medication

Counter check prescription

© IAH 2007 33

33
 Treatment with the three pillars

Basic preparation
Indication based Symptomatic
Homaccord

Detox and Drainage

Support Three pillars
regulation
Immunomodulation

Organ regulation
and cellular activation

© IAH 2007 34

In every indication there is a basic treatment, which will be specific for that
indication.
This will thus always vary, according to the condition we are treating, and it will
be organ or tissue specific, but not a tissue remedy in general,
The regulatory pillars though, are often the same in different diseases, as we are
treating the regulatory system, and this is the same in all diseases.
The only difference in the pillars is whether we will do a basic or advanced, and
whether we will adjust for other differences, such s TH1 or TH2.
One can thus compare it to an iceberg. The basic symptomatic treatment treats
the part above the water, the three pillars the large part below.
The following slides will give an example of each phase.

34
Example 1: Patient with increased sweating with
body odor

• Classify on DET Excretion

Epidermal

• Choose the appropriate pillar

• Drainage, thus
• Basic preparation: Schwef-Heel
• Drainage: Detox-Kit
• Check medication for appropriateness:
9PPG, MPG
9Special Heel combination

© IAH 2007 35

35
 Example 2: Patient with recurrent boils

• Classify on DET Inflammation

Epidermal

• Choose the appropriate pillar

• Basic treatment: Belladonna-Homaccord
• Basic immunomodulation: Traumeel
• Basic Detox and Drainage: Detox-Kit for 6 weeks
• Check medication for appropriateness:
9PPG, MPG
9Special Heel combination
9Homaccord

© IAH 2007 36

If a patient is in the inflammation phase, we want to stimulate excretion, and

modulate the inflammatory process, so that it does not become chronic, or too
robust (see BT Spring 2007 - Smit A A: Is Inflammation after Injury All Bad?
Journal of Biomedical Therapy 2007 1(1):16-17
Again in this example, the patient is to the upper left of the DET.
We are going to use a basic preparation, a basic immuno-modulator and a basic
detox kit.
On countercheck we need to see a PPG, MPG and drug-wise, a basic
combination and/or a homaccord (Detox Kit, Basic treatment).

36
 Example 3: Patient with kidney stones
Deposition
• Classify on DET
Mesodermal
nephrodermal
• Choose the appropriate pillar
• Basic preparation: Reneel
• Drainage: Detox-Kit for 12 weeks, add
• Organ support: Berberis-Homaccord, Coenzyme compositum
(functional and catalysts)
• Check medication for appropriateness:
9PPG, MPG, CPG
9Special Heel combination
9Homaccord
9Catalyst

© IAH 2007 37

When we treat diseases in the deposition phase, we often also add a catalyst, as
this will have an activating effect on the tissues.
Sometimes, if the deposition has been there for a longer period of time, we also
add organ products, but usually the functional support is enough.

37
 Example 4: Patient with Idiopathic
Thrombocytopaenic purpura (ITP)

• Classify on DET Impregnation

Mesodermal
Haemodermal
Blood
• Choose the appropriate pillar
• Basic preparation: Ceanothus-Homaccord
• Det & Drain: Advanced support 6 weeks and then Detox-Kit
12 weeks,
• Organ support: Tonsilla compositum (Immune regulation and organ
support) Coenzyme compositum plus Ubichinon compositum
• Check medication for appropriateness:
9PPG, MPG, CPG, ORPG
9Basic combination, Homaccords, Compositum, Catalyst

© IAH 2007 38

When we treat patients in the impregnation phase we need to be aggressive, as

we do have a chance here to tip compensation back into regulation.
We would thus add two catalysts, a compositum with organ extracts and do an
advanced detox.
In this case, Ceanothus-Homaccord is specific for the spleen, and helps with the
sequestration of platelets in the spleen, while Tonsilla is used to try and induce
oral tolerance in the bone marrow (it contains medulla ossis suis).
One then expects the patient to present with phenomena which we see on the left
side of the regulatory division, such as skin tags, (deposition), acute inflammation
(such as tendonitis or dermatitis) and with excretion( common cold, sweating,
slight diarrhea etc.).
Normally two of three cycles of this regulatory treatment is needed before the
disease will go into remission.
In this case, the petechia will be reduced and the platelet count should come up
and stabilize.

38
 Example 5: Patient with Chronic Obstructive
Airway Disease

• Classify on DET degeneration

Mesodermal
Cavodermal

• Choose the appropriate pillar

• Basic preparation: Bronchalis-Heel, Tartephedreel
• Det & Drain: Organ support 6 weeks and then Detox Kit 12 weeks
• Immune regulation and organ support : Mucosa compositum
• Cellular activation: Coenzyme compositum plus Ubichinon comp
• Check medication for appropriateness:
9PPG, MPG, CPG, ORPG
9Basic Heel combination, Homaccord, Compositum, Catalyst

© IAH 2007 39

The pattern should thus be clear:

The more to the right and the bottom of the chart we go, the more we have to add
tissue medications and catalysts.
The pillars are getting more advanced, and the treatment time longer.
In cases like these where there is tissue destruction, we try to support the organs.
In this case we can also use Funiculus umbilicalis suis Injeel, if available (is also
in Placenta compositum) to support the connective tissue.
Catalysts are mandatory in diseases classified in this phase.

39
 Example 6: Patient with Ca Breast
Dedifferentiation
• Classify on DET Endodermal
Exocrine
sexuel
• Choose the appropriate pillar
• Basic preparation: Ginseng compositum
• Detox & Drainage: Organ support 6 weeks and then Detox-Kit 12
weeks
(start D&D 6 weeks after chemo NOT during)
• Immune regulation: Viscum compositum
• Organ support: Mamma suis-Injeel
• Catalyst: Glyoxal compositum followed by Coenzyme compositum
and Ubichinon compositum
• Check medication for appropriateness:
9PPG, MPG, CPG, ORPG
9Basic Heel combination, Homaccord, Compositum, Catalyst, Injeel

© IAH 2007 40

For a patient in the last right phase we need to do all we can to restore
regulation.
Thus, all the advanced pillars are used in such a patient.
Especially the advanced catalysts are important to use here.
The appropriate tissue remedy is also used if available, otherwise a medication
rich in embryological tissue can be used, such as Placenta comp or Thyreoidea
comp.
Patients on Chemo are NEVER detoxed and drained during the active chemo
phase, as one wants the drugs to work in the tissues.
Six weeks after the last chemo, detox and drainage may then be started.
During the chemo phase, the patient can be supported with Hepar comp for the
liver, Tonsilla comp for the immune system and bone marrow, and Mucosa comp
for the mucous membranes.
These advanced support products do not drain, but mostly support the organ(s).

40
 How do I apply the three pillars?

• The three pillars are designed to induce regulation

• It thus stimulates the patient’s own ability to regulate
• They are not applied indefinitely, but in cycles, with time for
assessment in between
• If the patient starts to regulate, the pillars may be adjusted or
continued, depending on how long the patient stays on the left of
the regulation/compensation division
• It often takes a few attempts of the body to really mount a
regulation response which will last
• Regulation needs to continue till at least three of four episodes
of self regulation are observed (see next slide)
• The basic, symptomatic medication is often given for longer
periods

© IAH 2007 41

Lastly, it is often asked, how long do I apply the pillars?

Here we use our map, the DET to guide us.
We use the regulation in cycles (mostly 6-12 weeks on, and 6 weeks off), and
then observe whether the patient will regulate by him or herself, which can be
either during the active treatment or during the rest phase.
The more to the right a patient moves on the table, the less acute diseases such
a patient gets.
Acute robust disease is a sign of good regulation, and mostly in the inflammation
phase.
We thus endeavor to get the patient to mount an acute inflammation, or go back
to the deposition phase at least, and as a best scenario to go to excretion
directly.
Sometimes, patients will stay on the left side of the division very short initially, but
we want this every time to last longer, and also increase in frequency (at least for
a while, as recurrent acute infections are also a sign of dysregulation).
Sometimes, a number of cycles are needed before a patient will “regulate”, in
other patients it can happen very fast, even if they have been on the left of the
regulation/compensation division for many years, so one needs to inform the
patient what one would expect, and also be prepared for anything.

41
Regulation Phenomena

• These signify events that take place to the left of where the
patient is on the DET:
• They include for example:
• Acute infections and inflammations classified in the
inflammation phase, e.g. tendonitis, or an acute bronchitis or
cold
• Deposition phenomena getting worse in patients who present
in the impregnation phase, e.g. a patient with chronic
allergies gets a temporary increase in polyposis, or a patient
in the impregnation phase gets an increase in so called soft
warts or skin tags

© IAH 2007 42

42
 Treatment of conditions to the left of the
regulation/compensation division

Humoral Phases Matrix phases Cellular Phases

Excretion Inflammation Deposition Impregnation Degeneration Dedifferention.-

phase phase
phase phase phase phase

Ectoder
mal

Endoder
mal
Pillar or pillars are applied
for a shorter time, till a shift
Mesen- is seen. In phase 1 and 2
chymal
often 6 weeks enough, in
Meso- phase 3 may need several
dermal cycles

Tissue regulation/compensation division

© IAH 2007 43

Treatment is shorter if the patient is on the left side of the division

43
 The importance of the regulation/compensation
division

Humoral Phases Matrix phases Cellular Phases

Excretion Inflammation Deposition Impregnation Degeneration Dedifferention.-

phase phase
phase phase phase phase

Ectoder
mal

Endoder
Three pillars are applied in
mal cycles, of mostly three months
with a rest period in between of
Mesen-
chymal 6 weeks, till a shift is seen in the
DET to the left (see above)
Meso-
dermal

Tissue regulation/compensation division

© IAH 2007 44

Several cycles may be needed.

Experience has shown that patients in the impregnation phase may take up to a
year to move to full health evolution or recovery.

44